🇺🇸 Nalbuphine in superficial cervical plexus block in United States

Nalbuphine in superficial cervical plexus block (Nalbuphine in superficial cervical plexus block) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Nalbuphine in superficial cervical plexus block in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Nalbuphine in superficial cervical plexus block approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nalbuphine in superficial cervical plexus block in United States?

Kasr El Aini Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.